Kraig Biocraft Laboratories (KBLB) Long-Term Investments (2021 - 2025)

Kraig Biocraft Laboratories has disclosed Long-Term Investments across 5 years of filings, most recently posting $494259.0 for Q4 2025.

• Long-Term Investments for Q4 2025 came in at $494259.0, down 21.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $494259.0 (down 21.18% YoY), and the FY2025 annual result was $494259.0, down 21.18% from the prior year.
• Long-Term Investments came in at $494259.0 for Q4 2025 at Kraig Biocraft Laboratories, roughly flat from $494478.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $744553.0 in Q1 2025 to a low of $397758.0 in Q3 2022.
• The 5-year median for Long-Term Investments is $481919.5 (2023), against an average of $510075.2.
• Across the five-year window, Long-Term Investments soared 43.93% in 2024 and retreated 22.23% in 2025, its largest moves.
• Kraig Biocraft Laboratories' Long-Term Investments stood at $437212.0 in 2021, then gained by 0.01% to $437251.0 in 2022, then gained by 12.8% to $493236.0 in 2023, then rose by 27.13% to $627065.0 in 2024, then fell by 21.18% to $494259.0 in 2025.
• The last three Long-Term Investments figures came in at $494259.0 (Q4 2025), $494478.0 (Q3 2025), and $649773.0 (Q2 2025), per Business Quant data.